IL91691A - T cell growth factor, method for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

T cell growth factor, method for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL91691A
IL91691A IL91691A IL9169189A IL91691A IL 91691 A IL91691 A IL 91691A IL 91691 A IL91691 A IL 91691A IL 9169189 A IL9169189 A IL 9169189A IL 91691 A IL91691 A IL 91691A
Authority
IL
Israel
Prior art keywords
growth factor
cell growth
preparation
same
pharmaceutical compositions
Prior art date
Application number
IL91691A
Other languages
English (en)
Other versions
IL91691A0 (en
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of IL91691A0 publication Critical patent/IL91691A0/xx
Publication of IL91691A publication Critical patent/IL91691A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5425—IL-9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
IL91691A 1988-09-19 1989-09-19 T cell growth factor, method for the preparation thereof and pharmaceutical compositions containing the same IL91691A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/246,482 US5208218A (en) 1988-09-19 1988-09-19 T cell growth factor glycoproteins

Publications (2)

Publication Number Publication Date
IL91691A0 IL91691A0 (en) 1990-06-10
IL91691A true IL91691A (en) 1997-07-13

Family

ID=22930867

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91691A IL91691A (en) 1988-09-19 1989-09-19 T cell growth factor, method for the preparation thereof and pharmaceutical compositions containing the same

Country Status (12)

Country Link
US (2) US5208218A (fr)
EP (1) EP0361284B1 (fr)
JP (1) JP3223260B2 (fr)
AT (1) ATE167519T1 (fr)
AU (1) AU621661B2 (fr)
CA (1) CA1341461C (fr)
DE (1) DE68928710T2 (fr)
DK (1) DK175845B1 (fr)
ES (1) ES2118058T3 (fr)
IE (1) IE81152B1 (fr)
IL (1) IL91691A (fr)
PT (1) PT91750B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
US5587302A (en) * 1988-09-19 1996-12-24 Ludwig Institute For Cancer Research T cell growth factor
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
US5414071A (en) * 1989-05-23 1995-05-09 Genetics Institute, Inc. Human cytokine IL-9
EP0502080A4 (en) * 1989-11-21 1993-02-10 The University Of Melbourne Anti-inflammatory compositions and methods
US5132109A (en) * 1990-10-05 1992-07-21 Ludwig Institute For Cancer Research Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof
US5250295A (en) * 1991-11-04 1993-10-05 The Regents Of The Univ. Of California Natural killer cell enhancing factor
WO1994006906A1 (fr) * 1992-09-18 1994-03-31 Merck & Co., Inc. ADN CODANT L'ENZYME DE CONVERSION DE L'INTERLEUKINE 1β PRECURSEUR MURIN
TW257792B (fr) * 1992-10-01 1995-09-21 Lilly Co Eli
US5643881A (en) * 1994-08-04 1997-07-01 Tampa Bay Research Institute Protein having anti-HIV activity and method for obtaining it
AU2007202406B2 (en) * 1995-08-24 2010-08-12 Ligand Pharmaceuticals Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
EP2241329A3 (fr) * 1995-08-24 2011-03-09 Ligand Pharmaceuticals Incorporated Anticorps anti-interleukin-9 ou anticorps du récepteur anti-interleukin-9 pour le traitment de la hyper-réponse bronchique
US6037149A (en) * 1995-08-24 2000-03-14 Magainin Pharmaceuticals Inc. DNA encoding human asthma associated factor 1
WO1998024904A2 (fr) * 1996-12-02 1998-06-11 Magainin Pharmaceuticals Inc. Variants de recepteur il-9, utilises pour le traitement et le diagnostic des allergies atopique, y compris l'asthme et les troubles apparentes
EP1401497B1 (fr) * 2001-06-08 2012-01-11 Genaera Corporation Procedes relatifs a la modulation de l'il-13
JP2005535572A (ja) * 2002-04-12 2005-11-24 メディミューン，インコーポレーテッド 組換え抗インターロイキン−９抗体
EP1622568B1 (fr) * 2003-05-14 2010-07-07 Bayer Pharmaceuticals Corporation Muteines d'un antagoniste de l'interleukine-9 et leurs methodes pharmacologiques d'utilisation
CA2710920A1 (fr) * 2007-12-28 2009-07-09 Kalos Therapeutics, Inc. Composes antiproliferatifs et leur utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636463A (en) * 1984-04-05 1987-01-13 Scripps Clinic And Research Foundation Antibodies to human interleukin-2 induced by synthetic polypeptides
US5006459A (en) * 1986-03-31 1991-04-09 T Cell Sciences, Inc. Therapeutic and diagnostic methods using soluble T cell surface molecules
US4935343A (en) * 1986-08-08 1990-06-19 Syntex (U.S.A.) Inc. Monoclonal antibodies for interleukin-1β
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
JPH04500363A (ja) * 1989-05-24 1992-01-23 アボツト・ラボラトリーズ 心房ペプチド誘導体

Also Published As

Publication number Publication date
EP0361284A3 (fr) 1990-09-05
IL91691A0 (en) 1990-06-10
US5157112A (en) 1992-10-20
ES2118058T3 (es) 1998-09-16
DE68928710T2 (de) 1999-02-11
DK458889A (da) 1990-03-20
US5208218A (en) 1993-05-04
DK458889D0 (da) 1989-09-18
DK175845B1 (da) 2005-03-29
CA1341461C (fr) 2004-10-26
AU621661B2 (en) 1992-03-19
IE81152B1 (en) 2000-05-03
ATE167519T1 (de) 1998-07-15
EP0361284A2 (fr) 1990-04-04
EP0361284B1 (fr) 1998-06-17
JPH034796A (ja) 1991-01-10
PT91750A (pt) 1990-03-30
AU4156389A (en) 1990-03-22
DE68928710D1 (de) 1998-07-23
JP3223260B2 (ja) 2001-10-29
PT91750B (pt) 1995-05-31
IE892983L (en) 1990-03-19

Similar Documents

Publication Publication Date Title
IL88472A0 (en) Mammalian interleukin-1 receptor protein dnas and expression vectors encoding them,processes for producing them and pharmaceutical compositions containing them
IL99628A0 (en) Backbone cyclic peptides,processes for their preparation and pharmaceutical compositions containing them
MY101972A (en) Primate interleukin - 4
AU3829089A (en) Fr901228 substance and preparation thereof
NO904904D0 (no) Fremgangsmaate for fremstilling av en polypeptidforbindelse
IL88151A0 (en) Interleukin-7,its preparation and compositions containing it
CA2066618A1 (fr) Plasmides renfermant de l'adn encodant la sequence d'acides amines du tcf-ii, cellules transformees a l'aide des plasmides et methode de production de substances biologiquement actives a l'aide des cellules transformees
IE892983L (en) Mammalian t-cell growth factor
NZ234048A (en) Interleukin-7 (il-7) receptor and pharmaceutical compositions
US4613459A (en) Lymphocyte growth factor
US4752573A (en) Use of tetrahydrobiopterin to enhance the proliferative activity of interleukin-2 on T cells
JO1589B1 (en) Ketones (quaternary hydroimidazo (4.1) benzo-diazepine-2) anti-viral
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
ATE148890T1 (de) Cyclische peptide mit substance p-und substance k-antagonistischer aktivität
DE69434997D1 (de) Menschliches Chondromodulin-I-Protein
ES2012004A6 (es) Procedimiento para preparar polipeptidos anfifilicos que tienen propiedades antibioticas, antimicrobianas, espermiticidas y antivirales"
AU6662890A (en) Stabilization and maintenance of the nerve growth factor biological activity by use of natural gangliosides or derivatives thereof
EP0163543A3 (fr) Stimulateur de cellules de moelle
IL84551A (en) Peptides,their preparation and pharmaceutical compositions containing them
IL110585A0 (en) Tripeptides, their preparation and pharmaceutical compositions containing them
CA2050477A1 (fr) Facteur de croissances des lymphocytes t
US4720482A (en) Pharmaceutical compositions containing one or more lymphocyte growth factors
IL93548A0 (en) Ws7622a,b,c and d substances,derivatives thereof,processes for the preparation thereof and pharmaceutical compositions containing the same
TW372873B (en) A novel anti-neoplastic cytokine
EP0473080A3 (en) Chondromodulin-i protein

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired